Akari Therapeutics Plc (AKTX)
16.00
-1.81
(-10.16%)
USD |
NASDAQ |
May 27, 16:00
15.38
-0.62
(-3.88%)
After-Hours: 17:46
Akari Therapeutics Cash from Investing (Quarterly) : 0.00 for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| DBV Technologies SA | -0.3011M |
| Cellectis SA | -6.187M |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -0.1037M |
| Autolus Therapeutics Plc | 95.99M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.484M |
| Cash from Financing (Quarterly) | 0.0529M |
| Free Cash Flow | -10.93M |
| Free Cash Flow Per Share (Quarterly) | -1.673 |
| Free Cash Flow to Equity (Quarterly) | -2.462M |
| Free Cash Flow to Firm (Quarterly) | -2.426M |
| Free Cash Flow Yield | -66.35% |